Worth reading
19Immaterial
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.This transaction
Liquidation of a Consolidated SubsidiaryDisclosing companyPhoenixBio Co.,Ltd.
Execution Date / Effective Date16 November 2026 local time (17 November 2026 Japan time)
Target company
Management of a consortium for research into the utility of PXB mice
Location Delaware, United StatesShare capital US$250,000Date of incorporation January 2016
Impact on Business Performance
The impact of the completion of the liquidation of the company on consolidated results is immaterial.
| Item | Details |
|---|---|
| Transaction name | Liquidation of a Consolidated Subsidiary |
| Name of the Subject Company | CMHL Consortium LLC |
| Business Description of the Subject Company | Management of a consortium for research into the utility of PXB mice |
| Location of the Subject Company | Delaware, United States |
| Capital Stock of the Subject Company | US$250,000 |
| Date of Establishment of the Subject Company | January 2016 |
| Voting rights ownership percentage | Before 100% (after not disclosed) |
| Impact on Business Performance | The impact of the completion of the liquidation of the company on consolidated results is immaterial. |
| Execution Date / Effective Date | 16 November 2026 local time (17 November 2026 Japan time) |
Items this document does not state (23)
Counterparty nameNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This disclosure does not explain the reason for the liquidation.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.